how would YOU possibly know ? still holding onto bankrupt Dendreon ??? now THAT was quite a winner !
Crammer mentions a thousand stocks every week so he's bound to have plenty that he can claim credit for. Its hysterical listening to him talk about biotech stocks where he is very limited in his understanding but he will take credit if the stocks go up. He's a momentum guy who tries not to offend ceos that he needs for his show. If one comes on he'll talk it up to death.
what do you know ? you expect companies in biotech to hit on every indication ? must be new to the game. if this was such a big deal why is the stock down 1% ? riddle me that answer mr. smarty
good to see little beachball putz is out of his/her stroller ! any other magical forecasts to share ??? even a broken clock is right twice a day so maybe there's hope for you. your THLD track record sure has been incredibly incorrect over the LAST FEW YEARS. any new pearls of "wisdom" to share ? Is mommie still working at THLD for Uncle Harold CEO ??? ha ha ha ha
It makes you wonder why -- even small public companies have a designated CFO. Maybe Fernandez is too green to handle the job, maybe the role is open in the hope THLD can attract a real one -- who knows ? It's no surprise that there has not been proper corporate governance with the previous clowns who bought their way on to the board through their equity stakes. Also, there's no reason to increase expenses until you get closer to revenues which has been tough to forecast.
I'm sure Fernandez & the other guy wanted some clarity on their situations. Maybe they're out looking for another job----as there's been lots of new exciting companies going public over the last few years & creating some real personal wealth while THLD has languished & done nothing. Living in the Bay Area isn't easy on a basic paycheck & limited equity ownership. That would be my guess.
What planet are you "living" on these day, mr. greenhorn ? get in the game.....IF that is remotely possible. Bet your med costs have gone up bigtime under obamacare
AMR is a small & difficult area to penetrate market opportunity ($300 mil) & the reason it was not included in smart people's estimates and financial models. As far as 2015 there is plenty coming starting with financial guidance on he 4Q earnings call. CHMP opinion (Jan/Feb) on astofase alfa MAA is upcoming. FDA decision on astofase alfa BLA submission in seen in first half '15 with potential launch of astofase alfa in US & Europe this year. Also possible data from ALXN's next gen complement inhibitors in '15. The list goes on & on. ALXN is one of biotech's cleanest growth stories & I'd look for upside revisions to consensus revenues & earning, driving the stock higher.
Clearly you are an idiot & don't have any clue as to what's going on at ALXN. Wow the stock is down 1% --- you really nailed it.
The CFO is mid-level ? The last time I checked Fernandez signs off on ALL financial disclosures & corporate filings. Did you not know that ?
Its apparent that you have no clue but this goes on at real companies. Fernandez would be called CFO if the company chose to give the designation. That is hardly an insignificant position for any public company where someone like Fernandez has to sign off on all financial documents. Even for a tiny company like THLD its about time they put in these agreements---maybe it will help them attract quality people.
Orszag looked like he was reading from company notes & was very uncomfortable spouting any investment advice----certainly understandable since his primary forte is talking about gov't politics & economics. I would hardly call him anything close to expert on the oil picture outside of his peripheral intellectual observations. Actually he looked & sounded like a fish out of water talking about the investment landscape.